Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 03, 2020The AML Sessions: IDH inhibitors26 minutesPlayIDH mutations are present in 20% of acute myeloid leukemia (AML) patients and the use of IDH-targeting agents has shown......moreShareView all episodesBy VJHemOnc4.522 ratingsNovember 03, 2020The AML Sessions: IDH inhibitors26 minutesPlayIDH mutations are present in 20% of acute myeloid leukemia (AML) patients and the use of IDH-targeting agents has shown......moreMore shows like VJHemOnc PodcastView allNEJM This Week316 ListenersPeerView Oncology & Hematology CME/CNE/CPE Video Podcast11 ListenersTreating Blood Cancers12 ListenersBlood Podcast52 ListenersBlood Cancer Talks51 Listeners
IDH mutations are present in 20% of acute myeloid leukemia (AML) patients and the use of IDH-targeting agents has shown...
November 03, 2020The AML Sessions: IDH inhibitors26 minutesPlayIDH mutations are present in 20% of acute myeloid leukemia (AML) patients and the use of IDH-targeting agents has shown......more
IDH mutations are present in 20% of acute myeloid leukemia (AML) patients and the use of IDH-targeting agents has shown...